Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

426 trials with published results (11%)

Research Maturity

2029 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.7%

306 terminated out of 3976 trials

Success Rate

86.9%

+0.4% vs benchmark

Late-Stage Pipeline

6%

239 trials in Phase 3/4

Results Transparency

21%

426 of 2029 completed with results

Key Signals

426 with results87% success306 terminated

Data Visualizations

Phase Distribution

2,755Total
Not Applicable (1511)
Early P 1 (33)
P 1 (626)
P 2 (346)
P 3 (173)
P 4 (66)

Trial Status

Completed2,029
Recruiting633
Unknown462
Terminated306
Active Not Recruiting193
Not Yet Recruiting179

Trial Success Rate

86.9%

Benchmark: 86.5%

Based on 2029 completed trials

Clinical Trials (3976)

Showing 20 of 20 trials
NCT05364372Not ApplicableCompleted

SMLI With Hispanic Cancer Survivors and Caregivers

NCT07739563Not ApplicableNot Yet RecruitingPrimary

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

NCT07739849Not ApplicableNot Yet RecruitingPrimary

Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in Hours, Not Days.

NCT07724535Phase 1RecruitingPrimary

18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy

NCT06192758Not ApplicableActive Not Recruiting

Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

NCT05754801Phase 2RecruitingPrimary

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer

NCT00038727Phase 3Completed

Diabetes Prevention Program Outcomes Study

NCT01169259Phase 3Active Not RecruitingPrimary

Vitamin D and Omega-3 Trial (VITAL)

NCT07735442Not ApplicableNot Yet RecruitingPrimary

BRIDGE-SIC Efficacy Trial

NCT01445483Completed

Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases

NCT05885048RecruitingPrimary

Impact of Gonadotoxic Therapies on Fertility

NCT07690904Not ApplicableNot Yet RecruitingPrimary

Algorithm-enabled Goals of Care Communication

NCT06801041Phase 2Recruiting

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

NCT07733973Not ApplicableNot Yet RecruitingPrimary

Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer

NCT03899155Phase 2RecruitingPrimary

Pan Tumor Rollover Study

NCT07298096Not ApplicableRecruitingPrimary

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

NCT06183151SuspendedPrimary

Capillary-Venous Paired Collection

NCT07517666Not ApplicableEnrolling By InvitationPrimary

Genetic Information for Families After Tumor Testing Study

NCT00923065Enrolling By Invitation

Data Collection, Clinical Care and Interventions in CCR, NCI

NCT07731425Not ApplicableNot Yet RecruitingPrimary

Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival

Scroll to load more

Research Network

Activity Timeline